This inventor holds 3 USPTO granted patents. Top assignee: Alphora Research Inc.. Active years: 2008-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2011
Title: The Innovations of Fabio Eduardo Silva E Souza
Introduction
Fabio Eduardo Silva E Souza is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of synthetic vitamin D analogs. With a total of three patents to his name, his work has garnered attention for its innovative approaches and practical applications.
Latest Patents
One of Fabio's latest patents focuses on the purification of Paricalcitol, a synthetic vitamin D analog. This process achieves a purity greater than 99.7% through crystallization from a solution in isopropyl acetate solvent, followed by filtration and vacuum drying. Isopropyl acetate is distinguished among commonly available and pharmaceutically acceptable solvents for its unique ability to precipitate Paricalcitol in such high purity, essentially free of isomers. Furthermore, Paricalcitol with a purity of at least 99.9% has demonstrated exceptional storage stability, making it a valuable asset in pharmaceutical applications.
Career Highlights
Fabio is currently employed at Alphora Research Inc., where he continues to advance his research and development efforts. His work at this company has positioned him as a key player in the field of pharmaceutical innovation.
Collaborations
Some of Fabio's coworkers include Ming Pan and Kathleen Da Silva Turcot, who contribute to the collaborative environment at Alphora Research Inc. Their combined expertise fosters a culture of innovation and excellence in research.
Conclusion
Fabio Eduardo Silva E Souza's contributions to the field of pharmaceuticals, particularly through his innovative purification methods, highlight his role as a significant inventor. His work not only advances scientific knowledge but also enhances the quality of pharmaceutical products available in the market.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile